Elevated Lipoprotein(a) Predicts ASCVD Risk Despite Low CAC Score: Study

USA: Based on data from multiple large cohort studies, researchers have concluded that higher levels of lipoprotein(a) are associated with an increased 15-year risk of developing atherosclerotic cardiovascular disease (ASCVD), independent of coronary artery calcium (CAC) scores. However, individuals with a CAC score of zero showed low actual event rates even when Lp(a) levels were elevated.
- Elevated lipoprotein(a) levels above 50 mg/dL were independently associated with a higher risk of atherosclerotic cardiovascular disease (ASCVD).
- The presence of coronary artery calcium (CAC >0) was strongly linked to increased cardiovascular risk.
- The association between lipoprotein(a) and ASCVD risk remained consistent across different CAC categories.
- Both lipoprotein(a) levels and CAC scores contributed independently to cardiovascular risk prediction.
- Individuals with a CAC score of zero had overall low event rates.
- Among those with CAC = 0, elevated lipoprotein(a) was associated with a modestly higher risk of cardiovascular events compared to lower levels.
- In individuals with detectable CAC, elevated lipoprotein(a) further increased cardiovascular risk.
- The highest risk was observed in participants with both high CAC scores (≥300) and elevated lipoprotein(a).
- Findings were consistent across different age and sex groups.
- Absolute risk was higher in individuals older than 50 years and in men.
- The results highlight the complementary role of CAC scoring and lipoprotein(a) measurement in improving cardiovascular risk assessment.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
